NYSE:IQV IQVIA (IQV) Stock Price, News & Analysis $275.44 -3.40 (-1.22%) Closing price 03:59 PM EasternExtended Trading$275.19 -0.25 (-0.09%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About IQVIA Stock (NYSE:IQV) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get IQVIA alerts:Sign Up Key Stats Today's Range$274.10▼$278.0450-Day Range$257.17▼$279.4752-Week Range$154.50▼$284.50Volume1.00 million shsAverage Volume1.43 million shsMarket Capitalization$45.39 billionP/E Ratio24.08Dividend YieldN/APrice Target$294.21Consensus RatingModerate Buy Company Overview IQVIA Holdings Inc. provides clinical research services, healthcare data and analytics, and technology solutions to pharmaceutical, biotechnology, medical-device, and other healthcare organizations. Its services support the development and commercialization of medicines and other healthcare products. The company’s offerings include clinical trial planning and management, real-world data and evidence, consulting, and software and technology platforms for life sciences research and commercial operations. IQVIA was formed through the 2016 merger of Quintiles and IMS Health and adopted the IQVIA name in 2017. Headquartered in Durham, North Carolina, IQVIA serves clients around the world. Ari Bousbib has led the company as chairman and chief executive officer since its formation.AI Generated. May Contain Errors. Read More IQVIA Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks74th Percentile Overall ScoreIQV MarketRank™: 3.7223570658 of 5 starsIQVIA scored higher than 74% of companies evaluated by MarketBeat, and ranked 46th out of 881 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.0 / 5Analyst RatingModerate Buy Consensus RatingIQVIA has received a consensus rating of Moderate Buy. The company's average rating score is 2.90, and is based on 2 strong buy ratings, 16 buy ratings, 2 hold ratings, and 1 sell rating.Upside/DownsideThe consensus price target for IQVIA is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageIQVIA has been the subject of 14 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about IQVIA's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth9.71% Earnings GrowthEarnings for IQVIA are expected to grow by 9.71% in the coming year, from $11.53 to $12.65 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of IQVIA is 33.47, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.56.Price to Earnings Ratio vs. SectorThe P/E ratio of IQVIA is 33.47, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 35.09.Price to Earnings Growth RatioIQVIA has a PEG Ratio of 2.34. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioIQVIA has a P/B Ratio of 6.68. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.88% of the float of IQVIA has been sold short.Short Interest Ratio / Days to CoverIQVIA has a short interest ratio ("days to cover") of 2.08, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in IQVIA has recently increased by 1.66%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldIQVIA does not currently pay a dividend.Dividend GrowthIQVIA does not have a long track record of dividend growth. News and Social Media4.5 / 5News Sentiment1.24 News SentimentIQVIA has a news sentiment score of 1.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 9 news articles for IQVIA this week, compared to 6 articles on an average week.Search Interest11 people have searched for IQV on MarketBeat in the last 30 days. This is an increase of 83% compared to the previous 30 days.MarketBeat Follows7 people have added IQVIA to their MarketBeat watchlist in the last 30 days. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, IQVIA insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $697,228.00 in company stock.Percentage Held by Insiders1.70% of the stock of IQVIA is held by insiders.Percentage Held by Institutions89.62% of the stock of IQVIA is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about IQVIA's insider trading history. Receive IQV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IQVIA and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IQV Stock News HeadlinesIQVIA: 3 Key Takeaways for Long-Term InvestorsNovember 9 at 8:32 PM | fool.comIQVIA Holdings Inc. (IQV) - What Are Investment Firms Saying About This Stock?November 7 at 2:14 AM | americanbankingnews.comFinancial Legend: “Big trouble ahead …”Dr. Martin D. Weiss, founder of Weiss Ratings and a two-time Congressional witness on financial institution risk, is warning of a looming $3 trillion threat in today's financial system. He says the same ratings agency practices that preceded the 2008 crisis are repeating themselves, while regulators stay quiet about the risks.November 10 at 1:00 AM | Weiss Ratings (Ad)IQVIA Holdings consensus price target increased by 22.36% to MX$6,163.28November 2, 2026 | msn.comLeerink Partners Reaffirms Their Buy Rating on IQVIA Holdings (IQV)October 31, 2026 | theglobeandmail.comIQVIA Holdings (IQV) Gets a Buy from TD CowenOctober 31, 2026 | theglobeandmail.com5 revealing analyst questions from IQVIA’s Q3 earnings callOctober 30, 2026 | msn.comIQVIA (NYSE:IQV) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst SaysOctober 30, 2026 | americanbankingnews.comSee More Headlines IQV Stock Analysis - Frequently Asked Questions How have IQV shares performed this year? IQVIA's stock was trading at $225.40 at the beginning of the year. Since then, IQV stock has increased by 22.2% and is now trading at $275.4410. How were IQVIA's earnings last quarter? IQVIA Holdings Inc. (NYSE:IQV) released its quarterly earnings data on Tuesday, October, 27th. The medical research company reported $3.34 earnings per share for the quarter, beating the consensus estimate of $3.26 by $0.08. The firm's revenue was up 8.0% compared to the same quarter last year. Read the conference call transcript. Is IQVIA buying back stock? IQVIA's Board of Directors approved a stock buyback program on Thursday, May 7th 2026, which authorizes the company to repurchase $2 billion in outstanding shares, according to EventVestor. This means that the company could purchase up to 6.8% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's management believes its shares are undervalued. Does IQVIA have any subsidiaries? IQVIA subsidiaries include Q2 Solutions, Linguamatics, Advanced Health Media LLC, DrugDev, Aileron Solutions, Novella Clinical LLC, 159 Solutions LLC, and others. When did IQVIA IPO? IQVIA (IQV) raised $900 million in an initial public offering on Thursday, May 9th 2013. The company issued 23,684,210 shares at $36.00-$40.00 per share. Who are IQVIA's major shareholders? IQVIA's top institutional shareholders include Sumitomo Mitsui Trust Group Inc. (0.48%), Assenagon Asset Management S.A. (0.20%), Artemis Investment Management LLP (0.18%) and Vontobel Holding Ltd. (0.17%). Insiders that own company stock include Ari Bousbib, Eric Sherbet, W Richard Staub, James G Berkshire, Kevin C Knightly, Keriann Cherofsky, Bhavik Patel and John G Danhakl. View institutional ownership trends. How do I buy shares of IQVIA? Shares of IQV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of IQVIA own? Based on aggregate information from My MarketBeat watchlists, some other companies that IQVIA investors own include NVIDIA (NVDA), Salesforce (CRM), PayPal (PYPL), Tesla (TSLA), Walt Disney (DIS), Adobe (ADBE) and Visa (V). Company Calendar Last Earnings10/27/2026Today11/10/2026Investor Day 202612/01/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (4m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 IQV's financial health is in the Green zone, according to TradeSmith. IQV has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNYSE:IQV CIK1478242 Webwww.iqvia.com Phone(919) 998-2000FaxN/AEmployees93,000Year Founded2016Price Target and Rating Average Price Target for IQVIA$294.21 High Price Target$346.00 Low Price Target$200.00 Potential Upside/Downside+6.8%Consensus RatingModerate Buy Rating Score (0-4)2.90 Research Coverage21 Analysts Profitability EPS (Trailing Twelve Months)$8.23 Trailing P/E Ratio24.08 Forward P/E Ratio21.77 P/E Growth2.48Net Income$1.36 billion Net Margins8.05% Pretax Margin8.97% Return on Equity30.02% Return on Assets6.52% Debt Debt-to-Equity Ratio2.18 Current Ratio0.83 Quick Ratio0.83 Sales & Book Value Annual Sales$16.31 billion Price / Sales2.78 Cash Flow$17.65 per share Price / Cash Flow15.61 Book Value$41.21 per share Price / Book6.68Miscellaneous Outstanding Shares164,800,000Free Float161,998,000Market Cap$45.39 billion OptionableOptionable Beta1.16 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NYSE:IQV) was last updated on 11/10/2026 by MarketBeat.com Staff. From Our PartnersBlack Friday Bombshell (for traders)For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredTwo charts tell you the future…Gold miners are posting record cash flows, outperforming every other sector, yet mining still makes up just 1%...Golden Portfolio | SponsoredIt’s now or neverAnthropic's Claude now generates more revenue than ChatGPT, and the company is about to go public at a $1.5 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IQVIA Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IQVIA With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
